Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Amazon
AMZN
|
+$842M |
| 2 |
NVIDIA
NVDA
|
+$559M |
| 3 |
Microsoft
MSFT
|
+$420M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Moderna
MRNA
|
+$365M |
Top Sells
| 1 |
Baidu
BIDU
|
+$628M |
| 2 |
Tesla
TSLA
|
+$424M |
| 3 |
Palo Alto Networks
PANW
|
+$417M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$415M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| 1 | Healthcare | 19.94% |
| 2 | Technology | 19.65% |
| 3 | Consumer Staples | 10.63% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Hudson Technologies
HDSN
$444M
| $1.15M | ﹤0.01% |
336,850
+30,901
| +10% | +$105K |
|
|
VRN
2602
DELISTED
Veren
VRN
| $1.15M | ﹤0.01% |
253,335
-1,713,000
| -87% | -$7.74M |
|
|
PDCO
2603
DELISTED
Patterson Companies, Inc.
PDCO
| $1.14M | ﹤0.01% |
+37,604
| New | +$1.14M |
|
2604
Emerson Radio
MSN
$8.89M
| $1.14M | ﹤0.01% |
967,688
-85,107
| -8% | -$100K |
|
|
CCRC
2605
DELISTED
China Customer Relations Centers, Inc
CCRC
| $1.14M | ﹤0.01% |
175,491
-23,300
| -12% | -$151K |
|
2606
Comstock Holding Companies
CHCI
$173M
| $1.14M | ﹤0.01% |
190,364
-79,110
| -29% | -$473K |
|
|
GTM
2607
ZoomInfo Technologies
GTM
$3.72B
| $1.14M | ﹤0.01% |
+21,800
| New | +$1.14M |
|
|
LOAN
2608
Manhattan Bridge Capital
LOAN
$61.3M
| $1.14M | ﹤0.01% |
144,691
-14,638
| -9% | -$115K |
|
2609
Kraft Heinz
KHC
$30.9B
| $1.13M | ﹤0.01% |
+27,800
| New | +$1.13M |
|
2610
SIFCO Industries
SIF
$46.3M
| $1.13M | ﹤0.01% |
112,634
-3,600
| -3% | -$36.2K |
|
|
NPKI
2611
NPK International Inc.
NPKI
$889M
| $1.13M | ﹤0.01% |
326,841
-388,500
| -54% | -$1.34M |
|
2612
Pixelworks
PXLW
$61.8M
| $1.13M | ﹤0.01% |
27,626
-50,546
| -65% | -$2.07M |
|
|
CNTG
2613
DELISTED
Centogene N.V. Common Shares
CNTG
| $1.13M | ﹤0.01% |
108,155
+60,406
| +127% | +$631K |
|
|
TCON
2614
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $1.13M | ﹤0.01% |
8,677
-3,353
| -28% | -$435K |
|
2615
Urban One Class D
UONEK
$34.6M
| $1.12M | ﹤0.01% |
223,900
-447,482
| -67% | -$2.25M |
|
2616
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.67B
| $1.12M | ﹤0.01% |
20,497
-31,003
| -60% | -$1.69M |
|
2617
Marker Therapeutics
MRKR
$12.4M
| $1.12M | ﹤0.01% |
+39,990
| New | +$1.12M |
|
2618
Cibus
CBUS
$71.5M
| $1.11M | ﹤0.01% |
5,538
+4,926
| +805% | +$990K |
|
2619
Union Bankshares
UNB
$118M
| $1.11M | ﹤0.01% |
30,733
-4,299
| -12% | -$156K |
|
|
ATCX
2620
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $1.11M | ﹤0.01% |
115,000
+21,500
| +23% | +$208K |
|
|
BNSO
2621
DELISTED
Bonso Electronic International
BNSO
| $1.11M | ﹤0.01% |
162,355
-15,745
| -9% | -$108K |
|
|
AGRX
2622
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.11M | ﹤0.01% |
418
+226
| +118% | +$601K |
|
|
AAT
2623
American Assets Trust
AAT
$1.27B
| $1.11M | ﹤0.01% |
29,800
-75,400
| -72% | -$2.81M |
|
2624
Cyclerion Therapeutics
CYCN
$7.88M
| $1.11M | ﹤0.01% |
14,237
+2,577
| +22% | +$201K |
|
2625
YPF
YPF
$10.7B
| $1.1M | ﹤0.01% |
235,644
-57,856
| -20% | -$271K |
|